Tanja Eisenblätter
Hogan Lovells International LLPHogan Lovells International LLP is among the top players in the healthcare and life sciences sector and comprehensively advises on various topics with a focus on regulatory and contractual advice pertaining to future technologies in the life sciences sector, such as novel therapies and cell therapies – Jörg Schickert (co-head of the European regulatory team), Ina Brock (product liability), Arne Thiermann (regulatory, compliance) and Matthias Schweiger (litigation) frequently take the lead here. The team also covers issues at the interfaces with public law and contract law as well as IP, IT, data protection and product liability, thus advising on digital healthcare as well as strategic cooperations between pharmaceutical and IT companies. Schickert and Brock jointly head the practice with Andreas von Falck, who focuses on life sciences as well as the chemical and high-tech industries and represents clients in patent disputes, and Tanja Eisenblätter, who is particularly well versed in medical device and pharmaceutical advertising law. Lutz Angerer regularly advises large pharmaceutical companies and private equity houses on licensing and M&A transactions.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'The team responds very quickly to inquiries. This means that smaller consultations in particular are carried out very promptly and quickly, which is extremely helpful and pleasant in everyday working life. The team's specialist knowledge and expertise is convincing.'
- 'Jörg Schickert is an outstanding lawyer who thoroughly analyzes problems in a very structured manner and quickly offers a suitable and practical solution.'
- 'Arne Thiermann: I enjoy working with him. He is extremely reliable and quick and responsive to client needs.'
- 'The firm has numerous lawyers with in-depth legal, technical and practical knowledge of the pharmaceutical industry.'
- 'Internationally versatile team that already covers various jurisdictions within the firm and has an even larger network of partner law firms. This meant that a complex issue was assessed very quickly.'
- 'Great competence and experience in the health sector and national legislation/case law, but also in-depth understanding of the relevant market with regard to international guidelines. Timely and careful work tailored to the needs of the company and the risk profile of the project. High availability and targeted communication.'
- 'Jörg Schickert is very experienced and highly competent in all aspects of life sciences law, including regulatory, contractual and advertising law issues. He and his team support mandates in a timely, solution-oriented manner and with very good availability.'
Key clients
- Amylyx
- Bundesverband Herzkranke Kinder e.V. (BVHK)
- BMS
- CatalYm
- Chiesi Farmaceutici S.p.A.
- Eli Lilly
- Mirati Therapeutics
- Regeneron
- Roche Diagnostics
Work highlights
- Advising Amylyx on market entry in Germany; Advice on pharmaceutical and pharmaceutical advertising law, the development of distribution systems, regulatory issues and the preparation of contracts.
- Advising Roche Diagnostics in the area of digital healthcare, including on data protection and regulatory aspects.
- Advising numerous clients on criminal law issues, particularly in the area of advertising law and product liability matters, such as product recalls.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Jörg Schickert
Hogan Lovells International LLPNext Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Arne Thiermann
Hogan Lovells International LLPPractice head
The lawyer(s) leading their teams.
Jörg Schickert, Tanja Eisenblätter, Andreas von Falck, Lutz Angerer, Ina Brock